However, there is a paucity of pooled prevalence data and associated haematological markers such as CD4+ T for thrombocytopenia in HIV patients, and pooled prevalence data may be helpful to develop health care policy and guidelines for preventive measures [10]. This evidence concerns the gene CD4 and Thrombocytopenia.